Cited by 84Blood Pressure and Hypertension StudiesObstructive Sleep Apnea ResearchHeart Rate Variability and Autonomic Control

Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension – Insights From the SYMPLICITY HTN-3 Trial –

Open access
Kario, Kazuomi, Bhatt, Deepak L., Kandzari, David E., Brar, Sandeep, Flack, John M., Gilbert, Colleen, Oparil, Suzanne, Robbins, Mark +2 more·2016·Circulation Journal

Abstract

BACKGROUND: Obstructive sleep apnea (OSA) is associated with activation of the sympathetic nervous system, and patients with this condition often experience elevated blood pressure (BP), increased BP variability, and nocturnal BP surges. METHODS AND RESULTS: The SYMPLICITY HTN-3 trial was a large prospective, randomized, blinded, sham-controlled trial of renal denervation for treatment of uncontrolled, apparently treatment-resistant hypertension. In a post hoc analysis, we examined the effect of renal denervation vs. sham control on office and ambulatory (including nocturnal) systolic BP in patients with and without OSA. 26% (94/364) of renal denervation subjects and 32% (54/171) of sham control subjects had OSA. Baseline office and nighttime systolic BP values were similar in both arms, including in subjects with and without OSA. Compared with sham control, renal denervation reduced the 6-month office systolic BP in subjects with (-17.0±22.4 vs. -6.3±26.1 mmHg, P=0.01) but not in subjects without OSA (-14.7±24.5 vs. -13.4±26.4 mmHg, P=0.64), P=0.07 for the interaction between treatment arm and OSA status. In those with sleep apnea, renal denervation was also associated with a reduction in maximum (-4.8±21.8 vs. 4.5±24.6 mmHg, P=0.03) and average peak (-5.6±20.4 vs. 3.2±22.4 mmHg, P=0.02) nighttime systolic BP. CONCLUSIONS: OSA subjects appeared to be responsive to renal denervation therapy. However, this hypothesis requires prospective testing. (Circ J 2016; 80: 1404-1412).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1253/circj.cj-16-0035

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. KARIO K et al. 2014; 64: 1071 -1078.
  2. Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, et al. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hyper- tension. Hypertension 2015; 65: 766 -774.
  3. Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): A multicentre, open-label, randomised controlled trial. Lancet 2015; 385: 1957 -1965.
  4. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393 -1401.

Cited by

Sorted by citations

Authors
Kario, K., Bhatt, D. L., Kandzari, D. E., Brar, S., Flack, J. M., Gilbert, C., Oparil, S., Robbins, M., Townsend, R. R., & Bakris, G.
Affiliations
  • Jichi Medical University (JP)
  • Brigham and Women's Hospital (US)
  • Piedmont Atlanta Hospital (US)
  • Medtronic (United States) (US)
  • SIU Medicine (US)
  • University of Alabama (US)
  • Vanderbilt University (US)
  • University of Pennsylvania (US)
  • University of Chicago (US)
Venue
Circulation Journal
Published
2016
Volume
80
Issue
6
Pages
1404-1412
ISSN
  • 1346-9843 (ISSN-L)
  • 1347-4820
OpenAlex
W2344184152
Cited by
84
References
43
Citations by year
2026: 2 · 2025: 3 · 2024: 11 · 2023: 9 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 10 · 2018: 12 · 2017: 8 · 2016: 11
FWCI
11.25
Type
journal article
Language
en
Open access
Locations
  • Circulation Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Heart Association
  • Bristol-Myers Squibb
  • Pfizer
  • AstraZeneca
  • Bayer
  • Sanofi
  • Boston Scientific Corporation
  • Boston VA Research Institute
  • Regeneron Pharmaceuticals
  • Amarin Corporation
  • Medicines Company
  • Omron Healthcare
  • Regado Biosciences
  • Belvoir Media Group
  • Dainippon Sumitomo Pharma
  • Eisai
  • Astellas Pharma
  • Teijin Pharma
  • St. Jude Medical
  • Relypsa
  • Duke Clinical Research Institute
  • Janssen Pharmaceuticals
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
renal denervation, obstructive sleep apnea, resistant hypertension, Symplicity HTN-3 trial, nocturnal blood pressure, sympathetic activation, ambulatory blood pressure, treatment-resistant hypertension
MeSH terms
Adult, Aged, Blood Pressure, Denervation, Drug Resistance, Female, Humans, Hypertension, Kidney, Male, Middle Aged, Renal Artery, Sleep Apnea, Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review